Sleep in addiction care
- Conditions
- Insomnia in patients with substance use disorderMental and Behavioural DisordersNonorganic sleep disorders
- Registration Number
- ISRCTN59953554
- Lead Sponsor
- Mental Health Group in North and Middle Limburg (GGZ Noord- en Midden-Limburg) (Netherlands)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 90
1. Both males and females, age limit: 65
2. Patients who are admitted for at least 5 weeks to an addiction clinic
3. Those who are clean i.e. addicted patients that do not use drugs/alcohol anymore
4. Score of 5 or higher in the Pittsburgh Sleep Quality Index (PSQI)
1. Patients with sleep problems other than problems of initiating or maintaining sleep
2. Diagnosis of severe depression, attention deficit hyperactivity disorder (ADHD)
3. Patients who have a primary benzodiazepine addiction
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Subjective sleep efficiency as measured by a sleep log. The sleep log will be recorded by the participants during the 6-week treatment period. The sleep log has several outcome measures: time in bed (TIB), total sleep time (TST), sleep onset latency (SOL), sleep efficiency (SE), wake after sleep onset (WASO) and number of awakenings (AWAK). <br>2. Sleep quality measured by the Pittsburgh Sleep Quality Index (PSQI) at timepoints T0, T1, T2, T3 and T4<br><br>Timepoints:<br>T0 = Day of clinical intake<br>T1 = 4th week of treatment<br>T2 = 6th week of treatment, before randomisation<br>T3 = At the end of sleep training<br>T4 = 2 months after the sleep training
- Secondary Outcome Measures
Name Time Method